JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
TRIP.COM-S
09961
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -13.96%25.95M | -21.06%51.78M | -20.74%30.17M | 1.96%65.59M | -7.19%38.06M | -12.76%64.33M | 35.90%41.01M | -27.07%73.74M | -35.95%30.18M | -65.56%101.11M |
Operating income | -13.96%25.95M | -21.06%51.78M | -20.74%30.17M | 1.96%65.59M | -7.19%38.06M | -12.76%64.33M | 35.90%41.01M | -27.07%73.74M | -35.95%30.18M | -65.56%101.11M |
Cost of sales | 36.89%-8.26M | 40.46%-19.27M | 27.45%-13.09M | -50.72%-32.37M | 3.81%-18.04M | 51.85%-21.48M | -4.67%-18.75M | 2.43%-44.6M | 5.65%-17.91M | 73.33%-45.71M |
Operating expenses | 36.89%-8.26M | 40.46%-19.27M | 27.45%-13.09M | -50.72%-32.37M | 3.81%-18.04M | 51.85%-21.48M | -4.67%-18.75M | 2.43%-44.6M | 5.65%-17.91M | 73.33%-45.71M |
Gross profit | 3.60%17.7M | -2.16%32.51M | -14.69%17.08M | -22.47%33.23M | -10.04%20.02M | 47.05%42.86M | 81.52%22.26M | -47.39%29.14M | -56.41%12.26M | -54.67%55.4M |
Selling expenses | 84.93%-85K | 5.96%-694K | 26.37%-564K | 68.35%-738K | 34.70%-766K | ---2.33M | ---1.17M | ---- | ---- | ---- |
Administrative expenses | 45.06%-13.88M | 18.10%-29.8M | -8.75%-25.27M | 27.11%-36.38M | 3.59%-23.24M | ---49.92M | ---24.1M | ---- | ---- | ---- |
Profit from asset sales | ---957K | ---- | ---- | 14,120.00%711K | ---- | -100.00%5K | ---- | --324.67M | ---- | ---- |
Revaluation surplus | -1,860.93%-24.57M | -741.23%-33.11M | 111.58%1.4M | 94.85%-3.94M | 64.30%-12.05M | 67.50%-76.5M | 40.82%-33.75M | -11,388.44%-235.36M | -991.46%-57.03M | 107.22%2.09M |
-Changes in the fair value of investment property | -1,860.93%-24.57M | -741.23%-33.11M | 111.58%1.4M | 94.85%-3.94M | 64.30%-12.05M | 67.50%-76.5M | 40.82%-33.75M | -11,388.44%-235.36M | -991.46%-57.03M | 107.22%2.09M |
Impairment and provision | 98.37%-19K | 35.37%-3.57M | -2,889.74%-1.17M | -144.58%-5.53M | ---39K | ---2.26M | ---- | ---- | ---- | ---- |
-Other impairment is provision | 98.37%-19K | 35.37%-3.57M | -2,889.74%-1.17M | -144.58%-5.53M | ---39K | ---2.26M | ---- | ---- | ---- | ---- |
Special items of operating profit | -84.08%164K | -1,171.53%-28.94M | -52.36%1.03M | -138.24%-2.28M | 329.82%2.16M | --5.95M | --503K | ---- | ---- | ---- |
Operating profit | -188.90%-21.65M | -326.11%-63.61M | 46.10%-7.49M | 81.84%-14.93M | 61.65%-13.9M | -169.39%-82.19M | 19.00%-36.26M | 106.05%118.45M | -229.66%-44.77M | -43.08%57.49M |
Financing cost | 7.07%-20.92M | 40.08%-45.2M | 51.60%-22.52M | 21.31%-75.44M | -2.76%-46.52M | 35.69%-95.86M | 21.11%-45.27M | -5.03%-149.06M | -10.97%-57.38M | -2.23%-141.92M |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -31.19%503K | 366.75%1.04M | 154.92%731K |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -119.26%-123.77M | 69.29%-9.6M | 56.22%-56.45M |
Earning before tax | -41.87%-42.57M | -20.41%-108.81M | 50.33%-30.01M | 49.25%-90.36M | 25.89%-60.42M | -15.71%-178.05M | 26.36%-81.53M | -9.79%-153.88M | -126.72%-110.71M | 16.63%-140.16M |
Tax | 1,864.66%6.14M | 85.06%-2.52M | -111.55%-348K | -188.31%-16.89M | -64.30%3.01M | -67.11%19.12M | -41.08%8.44M | 252.67%58.14M | 687.61%14.32M | -362.55%-38.08M |
After-tax profit from continuing operations | -20.01%-36.43M | -3.80%-111.33M | 47.12%-30.36M | 32.52%-107.25M | 21.45%-57.41M | -65.99%-158.93M | 24.17%-73.09M | 46.28%-95.74M | -88.01%-96.39M | -1.07%-178.24M |
After-tax profit from non-continuing business | ---- | ---- | ---- | 14.90%-6.96M | ---1.05M | ---8.18M | ---- | ---- | ---- | ---- |
Earning after tax | -20.01%-36.43M | 2.53%-111.33M | 48.07%-30.36M | 31.65%-114.22M | 20.02%-58.46M | -74.54%-167.11M | 24.17%-73.09M | 46.28%-95.74M | -88.01%-96.39M | -1.07%-178.24M |
Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -352.11%-10.4M | -7,067.57%-2.65M | -56.85%-2.3M |
Shareholders should account for profits from continuing business | ---- | -3.80%-111.33M | ---- | 32.52%-107.25M | ---57.41M | ---158.93M | ---- | ---- | ---- | ---- |
Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | 14.90%-6.96M | ---1.05M | ---8.18M | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -20.01%-36.43M | 2.53%-111.33M | 48.07%-30.36M | 31.65%-114.22M | 20.02%-58.46M | -95.82%-167.11M | 22.03%-73.09M | 51.49%-85.34M | -82.97%-93.73M | -0.60%-175.94M |
Basic earnings per share | -19.59%-0.0116 | 2.47%-0.0356 | 48.13%-0.0097 | 31.65%-0.0365 | 20.09%-0.0187 | -95.60%-0.0534 | 22.00%-0.0234 | 51.77%-0.0273 | -80.72%-0.03 | 0.18%-0.0566 |
Diluted earnings per share | -19.59%-0.0116 | 2.47%-0.0356 | 48.13%-0.0097 | 31.65%-0.0365 | 20.09%-0.0187 | -95.60%-0.0534 | 22.00%-0.0234 | 51.77%-0.0273 | -80.72%-0.03 | 0.18%-0.0566 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Hang Kin Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.